The Report "European Drug Delivery Technology Market (Metered Dose Inhalers, Needle-free Injectors, Auto-injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release,...
The Report "European Drug Delivery Technology Market (Metered Dose Inhalers, Needle-free Injectors, Auto-injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release,...
VANCOUVER, BC and MESA, AZ, June 19, 2013 /PRNewswire/ - Avidus Management Group Inc. ("Avidus" or the "Company") (TSX-V: AVD, OTC: ASNHF) and its wholly owned subsidiary, Asantae, today announced that it held strategic...
VANCOUVER, BC and MESA, AZ, June 19, 2013 /PRNewswire/ - Avidus Management Group Inc. ("Avidus" or the "Company") (TSX-V: AVD, OTC: ASNHF) and its wholly owned subsidiary, Asantae, today announced that it held strategic...
Voices Against Brain Cancer (VABC), a not-for-profit organization dedicated to finding a cure for brain cancer, today announced that it has awarded Tocagen Inc. (www.tocagen.com) a grant to support the clinical investigation...
Voices Against Brain Cancer (VABC), a not-for-profit organization dedicated to finding a cure for brain cancer, today announced that it has awarded Tocagen Inc. (www.tocagen.com) a grant to support the clinical investigation...
NeuroDerm, Ltd. today announced that results from a phase I study in volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, were presented at the 2013 International...
NeuroDerm, Ltd. today announced that results from a phase I study in volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, were presented at the 2013 International...
Amerivet Solutions, LLC (AMERIVET), a unique sourcing company servicing all branches of government from Federal to Municipal, is pleased to announce that they have expanded their facilities to include complex metal design...
Amerivet Solutions, LLC (AMERIVET), a unique sourcing company servicing all branches of government from Federal to Municipal, is pleased to announce that they have expanded their facilities to include complex metal design...
Pharma IQ is pleased to announce the release of a brand new infographic summary of the results from an industry survey conducted earlier this year. Nearly a third of all respondents stated that CROs would be an area of...
Pharma IQ is pleased to announce the release of a brand new infographic summary of the results from an industry survey conducted earlier this year. Nearly a third of all respondents stated that CROs would be an area of...
A new blood test developed in the Gastrointestinal Cancer Research Lab at Baylor Research Institute is showing very promising results for finding cancer-related microRNA in the blood before a tumor develops in the colon.
A new blood test developed in the Gastrointestinal Cancer Research Lab at Baylor Research Institute is showing very promising results for finding cancer-related microRNA in the blood before a tumor develops in the colon.
Patient Advocate Foundation's (PAF) professional case managers were recently honored by Dorland Health, a division of Access Intelligence, with a Case In Point Platinum Award recognizing outstanding case management...
Patient Advocate Foundation's (PAF) professional case managers were recently honored by Dorland Health, a division of Access Intelligence, with a Case In Point Platinum Award recognizing outstanding case management...
Among the select few physicians honored with the prestigious Patients' Choice Award this year is Dr. Lawrence Inra.
Among the select few physicians honored with the prestigious Patients' Choice Award this year is Dr. Lawrence Inra.
MISSISSAUGA, ON, June 18, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain announced today that, at its 2013...
MISSISSAUGA, ON, June 18, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI) a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain announced today that, at its 2013...
Primary care and behavioral health transformation is taking SHAPE in Oregon and Colorado.
Primary care and behavioral health transformation is taking SHAPE in Oregon and Colorado.
Janssen Research & Development, LLC (Janssen) announced today that 17 presentations on INVOKANA™ (canagliflozin) ? including Phase 3 clinical safety and efficacy data, and a health economic analysis ? will be made at the...
Janssen Research & Development, LLC (Janssen) announced today that 17 presentations on INVOKANA™ (canagliflozin) ? including Phase 3 clinical safety and efficacy data, and a health economic analysis ? will be made at the...
Freudenberg has launched the "ideaTrophy", a business idea competition open to both Freudenberg employees and outside applicants such as new technology providers, research institutes and start-ups. Ideas in the fields of...
Freudenberg has launched the "ideaTrophy", a business idea competition open to both Freudenberg employees and outside applicants such as new technology providers, research institutes and start-ups. Ideas in the fields of...
Pro football player and 2012 most valuable player (MVP) Adrian Peterson and professional family expert Jo Frost have potentially life-threatening (severe) allergies and are partnering with Mylan Specialty L.P., the fully...
Pro football player and 2012 most valuable player (MVP) Adrian Peterson and professional family expert Jo Frost have potentially life-threatening (severe) allergies and are partnering with Mylan Specialty L.P., the fully...
Research and Markets (http://www.researchandmarkets.com/research/4bc2fv/rheumatology) has announced the addition of the "Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the...
Research and Markets (http://www.researchandmarkets.com/research/4bc2fv/rheumatology) has announced the addition of the "Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the...
Vitera Healthcare Solutions, the nation's premier provider of ambulatory electronic health records (EHR) and practice management software and services, today announced the acquisition of SuccessEHS. The acquisition...
Vitera Healthcare Solutions, the nation's premier provider of ambulatory electronic health records (EHR) and practice management software and services, today announced the acquisition of SuccessEHS. The acquisition...
MISSISSAUGA, ON and MONTREAL, QC, June 17, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the...
MISSISSAUGA, ON and MONTREAL, QC, June 17, 2013 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the...
The law firm of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP has just commenced what is believed to be the first suit in New York for the development of pancreatic cancer in the user of three common anti-diabetic...
The law firm of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP has just commenced what is believed to be the first suit in New York for the development of pancreatic cancer in the user of three common anti-diabetic...
Bharat Book Bureau presents China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration...
Bharat Book Bureau presents China Pharmaceutical Guidebook: Latest Chinese Regulations for Imported Drug Registration...
Comprehensive training program includes documentation improvement support; program promoted through new 'Wake-Up Call' campaign and ICD-10 launch countdown app Elsevier, a world-leading provider of scientific,...
Comprehensive training program includes documentation improvement support; program promoted through new 'Wake-Up Call' campaign and ICD-10 launch countdown app Elsevier, a world-leading provider of scientific,...
Roper Industries, Inc. (NYSE: ROP) announced that its Board of Directors has approved a dividend of $0.165 per share payable on July 26, 2013 to stockholders of record on July 12, 2013.
Roper Industries, Inc. (NYSE: ROP) announced that its Board of Directors has approved a dividend of $0.165 per share payable on July 26, 2013 to stockholders of record on July 12, 2013.
Janssen Research & Development, LLC (Janssen) today welcomes the World Health Organization (WHO) interim policy guidance on the use of bedaquiline (trade name SIRTURO™ in the U.S.) in the treatment of pulmonary...
Janssen Research & Development, LLC (Janssen) today welcomes the World Health Organization (WHO) interim policy guidance on the use of bedaquiline (trade name SIRTURO™ in the U.S.) in the treatment of pulmonary...
During its meeting on June 5, 2013, the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation, approved $10.95 million in funding for fourteen new projects between Israeli and...
During its meeting on June 5, 2013, the Board of Governors of the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation, approved $10.95 million in funding for fourteen new projects between Israeli and...
Array BioPharma Inc. (NASDAQ: ARRY) today announced that interim results from an ongoing ARRY-520 clinical trial in multiple myeloma (MM) were presented at the 2013 Congress of the European Hematology Association in...
Array BioPharma Inc. (NASDAQ: ARRY) today announced that interim results from an ongoing ARRY-520 clinical trial in multiple myeloma (MM) were presented at the 2013 Congress of the European Hematology Association in...
BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX) – Financial personality and Founder of NBT Equities Research, Tobin Smith, recently interviewed BioRestorative Therapies, Inc. (the "Company") CEO, Mark...
BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: BRTX) – Financial personality and Founder of NBT Equities Research, Tobin Smith, recently interviewed BioRestorative Therapies, Inc. (the "Company") CEO, Mark...
Ambrx and Zhejiang Medicine Co. Ltd. (ZMC) today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate (ADC)...
Ambrx and Zhejiang Medicine Co. Ltd. (ZMC) today announced that they have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced internally developed site-specific antibody drug conjugate (ADC)...
June During the SUMMER, we all face an increased chance of exposure to the triggers and other precipitating factors of Headache. Vacations, air travel, the beach, picnics, and partying are not always fun times – especially...
June During the SUMMER, we all face an increased chance of exposure to the triggers and other precipitating factors of Headache. Vacations, air travel, the beach, picnics, and partying are not always fun times – especially...
Validation of novel system for high-throughput 3D imaging of toxicologic phenotypes to be presented in scientific workshop and poster at STP 2013 in Portland, OR
Validation of novel system for high-throughput 3D imaging of toxicologic phenotypes to be presented in scientific workshop and poster at STP 2013 in Portland, OR
Research and Markets (http://www.researchandmarkets.com/research/dfcq6z/gene_therapy) has announced a new report "Gene Therapy - Technologies, Markets and Companies" to its offering. (Logo:...
Research and Markets (http://www.researchandmarkets.com/research/dfcq6z/gene_therapy) has announced a new report "Gene Therapy - Technologies, Markets and Companies" to its offering. (Logo:...
TORONTO, June 17, 2013 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that Eli Lilly and Company ("Lilly") has exercised its option to assume all development...
TORONTO, June 17, 2013 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that Eli Lilly and Company ("Lilly") has exercised its option to assume all development...
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced results from a pooled analysis of data from completed Phase 1 and 2 studies of pacritinib, an oral JAK2/FLT3 inhibitor, demonstrating the safety and...
Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced results from a pooled analysis of data from completed Phase 1 and 2 studies of pacritinib, an oral JAK2/FLT3 inhibitor, demonstrating the safety and...
Waters Corporation (NYSE: WAT) today introduced CORTECS™ Columns, a new family of 1.6 micron solid-core UltraPerformance LC® Columns that set a new standard in LC column performance. The higher efficiency brought to...
Waters Corporation (NYSE: WAT) today introduced CORTECS™ Columns, a new family of 1.6 micron solid-core UltraPerformance LC® Columns that set a new standard in LC column performance. The higher efficiency brought to...
Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), an integrated physician-driven healthcare delivery company that puts 'Patients First,' today announced its fiscal 2014 first quarter results for the three ...
Apollo Medical Holdings, Inc. ("ApolloMed") (OTCQB: AMEH), an integrated physician-driven healthcare delivery company that puts 'Patients First,' today announced its fiscal 2014 first quarter results for the three ...
Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from the RELY-ABLE® trial, a long-term extension of the pivotal RE-LY® study of Pradaxa® (dabigatran etexilate mesylate) capsules in patients with...
Boehringer Ingelheim Pharmaceuticals, Inc. today announced results from the RELY-ABLE® trial, a long-term extension of the pivotal RE-LY® study of Pradaxa® (dabigatran etexilate mesylate) capsules in patients with...
Today, Wall Street Reports announced new research reports highlighting Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Questcor...
Today, Wall Street Reports announced new research reports highlighting Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Questcor...
IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented...
IntelliCell BioSciences, Inc. ("Company") (SVFC) announces that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell's proprietary patented...
- Pharmaceutical, energy, and technology giants among companies adopting unique e-Invoicing services in Mexico Twelve months after processing its first electronic invoice in Mexico, the combined services from OB10...
- Pharmaceutical, energy, and technology giants among companies adopting unique e-Invoicing services in Mexico Twelve months after processing its first electronic invoice in Mexico, the combined services from OB10...
NeuroDerm, Ltd. today announced that abstracts reporting results from a phase I study in healthy volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, have been selected...
NeuroDerm, Ltd. today announced that abstracts reporting results from a phase I study in healthy volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, have been selected...
Results from a Janssen Research & Development, LLC (Janssen)-sponsored Phase 3 study published today in The Lancet showed patients with active psoriatic arthritis who received either STELARA® (ustekinumab) 45 mg or 90 mg...
Results from a Janssen Research & Development, LLC (Janssen)-sponsored Phase 3 study published today in The Lancet showed patients with active psoriatic arthritis who received either STELARA® (ustekinumab) 45 mg or 90 mg...
Royalty Pharma today announces that as of 5:30 pm EDT on Wednesday, June 12, 2013 holders of approximately 276 million Elan ADSs (NYSE: ELN), representing more than 70% of the Elan ADSs held in street name, had voted on the...
Royalty Pharma today announces that as of 5:30 pm EDT on Wednesday, June 12, 2013 holders of approximately 276 million Elan ADSs (NYSE: ELN), representing more than 70% of the Elan ADSs held in street name, had voted on the...
BELLEVILLE, ON, June 12, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today issued an open letter to all shareholders from...
BELLEVILLE, ON, June 12, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today issued an open letter to all shareholders from...
Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcement dated June 6, 2013, regarding the acceleration notice received from Bank Hapoalim B.M. ("Bank"),...
Elbit Imaging Ltd. ("EI" or the "Company") (TASE, NASDAQ: EMITF) announced today, further to the Company's announcement dated June 6, 2013, regarding the acceleration notice received from Bank Hapoalim B.M. ("Bank"),...
Remedi SeniorCare® is pleased to announce that Carol Slas, RPh, has joined their expanding team as the General Manager of the Marshall, Michigan pharmacy.
Remedi SeniorCare® is pleased to announce that Carol Slas, RPh, has joined their expanding team as the General Manager of the Marshall, Michigan pharmacy.
Micell Technologies, Inc. received CE (Conformite Europeenne) Mark approval for its MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES®) introducing a thin-strut stent that features elimination...
Micell Technologies, Inc. received CE (Conformite Europeenne) Mark approval for its MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES®) introducing a thin-strut stent that features elimination...
At the Association for Health Insurance Plan's (AHIP) conference this Thursday, medical directors from Cardinal Health Specialty Solutions and Aetna (NYSE: ?ET) will provide expert insight into how collaboration between...
At the Association for Health Insurance Plan's (AHIP) conference this Thursday, medical directors from Cardinal Health Specialty Solutions and Aetna (NYSE: ?ET) will provide expert insight into how collaboration between...
AMRI (NASDAQ: AMRI) announced today that Thomas E. D'Ambra, Ph.D., President and Chief Executive Officer at AMRI, will present at the 2013 Wells Fargo Securities Healthcare Conference on Wednesday, June 19, 2013 at 10:40...
AMRI (NASDAQ: AMRI) announced today that Thomas E. D'Ambra, Ph.D., President and Chief Executive Officer at AMRI, will present at the 2013 Wells Fargo Securities Healthcare Conference on Wednesday, June 19, 2013 at 10:40...
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that ongoing KRYSTEXXA® (pegloticase) post-marketing surveillance data describing the long-term safety data for KRYSTEXXA will be presented at the 2013 EULAR...
Savient Pharmaceuticals, Inc. (NASDAQ: SVNT) today announced that ongoing KRYSTEXXA® (pegloticase) post-marketing surveillance data describing the long-term safety data for KRYSTEXXA will be presented at the 2013 EULAR...
AURORA, ON, June 12, 2013 /CNW/ - Prollenium Medical Technologies Inc. has opened its new facility, just north of Toronto, making it the only manufacturer of dermal fillers for tissue reconstruction in Canada. Prollenium is...
AURORA, ON, June 12, 2013 /CNW/ - Prollenium Medical Technologies Inc. has opened its new facility, just north of Toronto, making it the only manufacturer of dermal fillers for tissue reconstruction in Canada. Prollenium is...
On 9th - 11th September, a selection of the region's most prominent C-level executives from across the pharmaceutical industry will convene at the Sheraton Mirasierra Hotel & Spa, Madrid at GDS International's...
On 9th - 11th September, a selection of the region's most prominent C-level executives from across the pharmaceutical industry will convene at the Sheraton Mirasierra Hotel & Spa, Madrid at GDS International's...
Shape an ideal path to reconstruction Following FDA approval for the US market in April, Mentor, leading global manufacturer of the highest quality breast implants is proud to announce the availability of the CPX™4 Tissue...
Shape an ideal path to reconstruction Following FDA approval for the US market in April, Mentor, leading global manufacturer of the highest quality breast implants is proud to announce the availability of the CPX™4 Tissue...
ThromboGenics NV (Euronext Brussels: THR) a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, announces today that the UK's National Institute for Health and Care...
ThromboGenics NV (Euronext Brussels: THR) a biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines, announces today that the UK's National Institute for Health and Care...
Spirit Health Networks' President and Chief Vision Officer, Tanya Abreu, is honored to be the keynote speaker at the 4th Annual International Women in Surgery Symposium in San Francisco this week. The symposium, founded...
Spirit Health Networks' President and Chief Vision Officer, Tanya Abreu, is honored to be the keynote speaker at the 4th Annual International Women in Surgery Symposium in San Francisco this week. The symposium, founded...
The phrase "age gracefully" has permeated American culture. It suggests a person who wishes to present an aged self to the world, but with dignity that transcends the fickle trappings of physical beauty. If this sounds...
The phrase "age gracefully" has permeated American culture. It suggests a person who wishes to present an aged self to the world, but with dignity that transcends the fickle trappings of physical beauty. If this sounds...
CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that Chief Financial...
CardioMEMS, Inc., an Atlanta-based medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body, today announced that Chief Financial...
Mirixa Corporation today announced that The Assist Group, Inc., the leader in high-dollar medical claims review and resolution, has selected Mirixa to conduct Medication Therapy Management (MTM) services for members of its...
Mirixa Corporation today announced that The Assist Group, Inc., the leader in high-dollar medical claims review and resolution, has selected Mirixa to conduct Medication Therapy Management (MTM) services for members of its...
Leonhardt Ventures and CORE Manufacturing, LLC, are pleased to announce a new partnership. Leonhardt Ventures has partnered with CORE Manufacturing to manufacture and bring to market a lineup of breakthrough medical...
Leonhardt Ventures and CORE Manufacturing, LLC, are pleased to announce a new partnership. Leonhardt Ventures has partnered with CORE Manufacturing to manufacture and bring to market a lineup of breakthrough medical...
Today e-pill Medication Reminders announced that a new device (e-pill Station) is being released for sale in the United States and Canada for patients on chronic medications with limited use of their hands such as patients...
Today e-pill Medication Reminders announced that a new device (e-pill Station) is being released for sale in the United States and Canada for patients on chronic medications with limited use of their hands such as patients...
Fisnar Inc.'s Free Robot Trial Service provides an opportunity to first prove an automated dispensing application using a Fisnar robot before purchasing equipment or allocating engineering time to justify an investment.
Fisnar Inc.'s Free Robot Trial Service provides an opportunity to first prove an automated dispensing application using a Fisnar robot before purchasing equipment or allocating engineering time to justify an investment.
Asthmapolis (az-MAP-o-lis), the FDA-cleared mobile health solution for asthma and COPD, will showcase its award-winning platform at America's Health Insurance Plans (AHIP) Institute, June 12-13 at the Wynn Las Vegas in...
Asthmapolis (az-MAP-o-lis), the FDA-cleared mobile health solution for asthma and COPD, will showcase its award-winning platform at America's Health Insurance Plans (AHIP) Institute, June 12-13 at the Wynn Las Vegas in...
Topics: Pharmaceutical Packaging, track and trace, anticounterfeiting, Pharmapack Pharmapack North America attendees can expect to hear from 22+ experts in their respective fields, and with recent developments will address...
Topics: Pharmaceutical Packaging, track and trace, anticounterfeiting, Pharmapack Pharmapack North America attendees can expect to hear from 22+ experts in their respective fields, and with recent developments will address...
MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that a randomized...
MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that a randomized...
Lakeland Industries, Inc. (NASDAQ: LAKE), a leading global manufacturer of protective clothing for industry, healthcare and to first responders on the federal, state and local levels, will release its financial results for...
Lakeland Industries, Inc. (NASDAQ: LAKE), a leading global manufacturer of protective clothing for industry, healthcare and to first responders on the federal, state and local levels, will release its financial results for...
June has been designated Migraine and Headache Awareness Month. This year's theme is "Unmasking the Mystery of Chronic Headaches." Almost 3.2 million Americans are missing work or school, are not able to perform daily...
June has been designated Migraine and Headache Awareness Month. This year's theme is "Unmasking the Mystery of Chronic Headaches." Almost 3.2 million Americans are missing work or school, are not able to perform daily...
AURORA, ON, June 10, 2013 /CNW/ - After another successful year, Prollenium Medical Technologies Inc. has been ranked no. 292 on the PROFIT 500 list of Canada's top 500 fastest-growing companies. The list was published...
AURORA, ON, June 10, 2013 /CNW/ - After another successful year, Prollenium Medical Technologies Inc. has been ranked no. 292 on the PROFIT 500 list of Canada's top 500 fastest-growing companies. The list was published...
TNI BioTech, Inc. (TNIB, the "Company") (OTCQB: TNIB) announced today that effective as of the opening of business on Monday June 10, 2013, the Company will require the mandatory exchange of all existing common stock...
TNI BioTech, Inc. (TNIB, the "Company") (OTCQB: TNIB) announced today that effective as of the opening of business on Monday June 10, 2013, the Company will require the mandatory exchange of all existing common stock...
Hovione today announced the appointment of Dr. Justin Hughey to lead the Particle Design sciences at our site in New Jersey. With over 30 publications, posters and book chapters Dr. Hughey is an acknowledged expert in the...
Hovione today announced the appointment of Dr. Justin Hughey to lead the Particle Design sciences at our site in New Jersey. With over 30 publications, posters and book chapters Dr. Hughey is an acknowledged expert in the...
In the news release, "Pharmafocusasia.com Releases its e-Book for Year 2013" issued on 6 Jun 2013 12:54 GMT, by Pharmafocusasia.com over PR Newswire, we are advised by a representative of the company that the contact number...
In the news release, "Pharmafocusasia.com Releases its e-Book for Year 2013" issued on 6 Jun 2013 12:54 GMT, by Pharmafocusasia.com over PR Newswire, we are advised by a representative of the company that the contact number...
Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of companies Debiopharm Group™, with a focus on the development of...
Diagnoplex SA, a developer of molecular diagnostics for colon cancer and Debiopharm Diagnostics SA, part of the Swiss-based global biopharmaceutical group of companies Debiopharm Group™, with a focus on the development of...
Research and Markets (http://www.researchandmarkets.com/research/7j9fvr/flow_cytometry) has announced the addition of the "Flow Cytometry 2013: A Focus on Sales Growth" report to their offering. (Logo:...
Research and Markets (http://www.researchandmarkets.com/research/7j9fvr/flow_cytometry) has announced the addition of the "Flow Cytometry 2013: A Focus on Sales Growth" report to their offering. (Logo:...
Piramal Imaging announced today that results from four studies evaluating the Company's PET amyloid imaging agent (florbetaben F18*) will be presented at the 2013 Annual Meeting of the Society of Nuclear Medicine and...
Piramal Imaging announced today that results from four studies evaluating the Company's PET amyloid imaging agent (florbetaben F18*) will be presented at the 2013 Annual Meeting of the Society of Nuclear Medicine and...
MONTREAL, June 6, 2013 /CNW/ - Abilify® (aripiprazole) has received an additional approval from Health Canada as an adjunct, or add-on, treatment to antidepressants for the treatment of major depressive disorder (MDD) in...
MONTREAL, June 6, 2013 /CNW/ - Abilify® (aripiprazole) has received an additional approval from Health Canada as an adjunct, or add-on, treatment to antidepressants for the treatment of major depressive disorder (MDD) in...
PDX, Inc. and Mirixa Corporation have entered into an agreement to integrate the MirixaPro?platform with both the PDX Classic Pharmacy System and the PDX Enterprise Pharmacy System. MirixaPro provides pharmacies with...
PDX, Inc. and Mirixa Corporation have entered into an agreement to integrate the MirixaPro?platform with both the PDX Classic Pharmacy System and the PDX Enterprise Pharmacy System. MirixaPro provides pharmacies with...
Following up on its commitment to invest Michigan private equity in Michigan-based companies, Blackford Capital today announced the acquisition of Mopec, Inc., a full-service, full-line manufacturer of pathology and mortuary...
Following up on its commitment to invest Michigan private equity in Michigan-based companies, Blackford Capital today announced the acquisition of Mopec, Inc., a full-service, full-line manufacturer of pathology and mortuary...
Pharmafocus Asia which reaches out to the top spending private and public Pharmaceutical and Pharma laboratories in addition to the national and regional Pharma authorities and Pharma ministries throughout Asia with its...
Pharmafocus Asia which reaches out to the top spending private and public Pharmaceutical and Pharma laboratories in addition to the national and regional Pharma authorities and Pharma ministries throughout Asia with its...
2Market Information Inc., publisher of Technology Transfer Tactics, has launched a new web portal – TechTransferCentral.com. The new site is designed to be a one-stop destination supplying information, news, products, and...
2Market Information Inc., publisher of Technology Transfer Tactics, has launched a new web portal – TechTransferCentral.com. The new site is designed to be a one-stop destination supplying information, news, products, and...
Editor Note: For more information about this release, please scroll to bottom. Today, Wall Street Reports announced new research reports highlighting Perrigo Company (NASDAQ: PRGO), Auxilium Pharmaceuticals, Inc. (NASDAQ:...
Editor Note: For more information about this release, please scroll to bottom. Today, Wall Street Reports announced new research reports highlighting Perrigo Company (NASDAQ: PRGO), Auxilium Pharmaceuticals, Inc. (NASDAQ:...
Lhasa Limited, a leading global supplier of knowledge based software and associated databases for use in toxicity, metabolism and the related sciences, today announces the development of a new product: Sarah Nexus, a...
Lhasa Limited, a leading global supplier of knowledge based software and associated databases for use in toxicity, metabolism and the related sciences, today announces the development of a new product: Sarah Nexus, a...
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced positive top-line results for EYLEA® (aflibercept) Injection from the Phase 3 MYRROR study in myopic choroidal neovascularization (mCNV)....
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced positive top-line results for EYLEA® (aflibercept) Injection from the Phase 3 MYRROR study in myopic choroidal neovascularization (mCNV)....
BELLEVILLE, ON, June 5, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC) ("Bioniche") and Paladin Labs Inc.(TSX: PLB) ("Paladin") today announced a comprehensive strategic collaboration to refinance and...
BELLEVILLE, ON, June 5, 2013 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC) ("Bioniche") and Paladin Labs Inc.(TSX: PLB) ("Paladin") today announced a comprehensive strategic collaboration to refinance and...
Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of SkinMelanoma.com, a website created to educate melanoma patients, their families and healthcare providers about...
Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of SkinMelanoma.com, a website created to educate melanoma patients, their families and healthcare providers about...
LISLE, IL, June 5, 2013 /PRNewswire/ - Catamaran (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Jeff Park, Executive Vice President and Chief...
LISLE, IL, June 5, 2013 /PRNewswire/ - Catamaran (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Jeff Park, Executive Vice President and Chief...
Research and Markets (http://www.researchandmarkets.com/research/bvckj3/drug) has announced the addition of the "Drug Self-Administration to 2018 Drug Products, Indications, Markets and Forecasts" report to their offering. ...
Research and Markets (http://www.researchandmarkets.com/research/bvckj3/drug) has announced the addition of the "Drug Self-Administration to 2018 Drug Products, Indications, Markets and Forecasts" report to their offering. ...
Research and Markets has announced the addition of the "Infusion Pumps Markets Worldwide" (http://www.researchandmarkets.com/research/vjvwj2/infusion_pumps) report to their offering. (Logo:...
Research and Markets has announced the addition of the "Infusion Pumps Markets Worldwide" (http://www.researchandmarkets.com/research/vjvwj2/infusion_pumps) report to their offering. (Logo:...
Research and Markets (http://www.researchandmarkets.com/research/ms3fjr/pharmaceuticals) has announced the addition of a new report "Pharmaceuticals Market Access Taiwan" to their offering. (Logo:...
Research and Markets (http://www.researchandmarkets.com/research/ms3fjr/pharmaceuticals) has announced the addition of a new report "Pharmaceuticals Market Access Taiwan" to their offering. (Logo:...
Compass Diversified Holdings (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that it will host an investor and analyst meeting on Wednesday, June 12, 2013 at 12:15 p.m....
Compass Diversified Holdings (NYSE: CODI) ("CODI" or the "Company"), an owner of leading middle market businesses, announced today that it will host an investor and analyst meeting on Wednesday, June 12, 2013 at 12:15 p.m....
PharmaRoth Labs, Inc. (OTCPink: ROTH), the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, is pleased to introduce the two newest members of the Company's Board of...
PharmaRoth Labs, Inc. (OTCPink: ROTH), the exclusive producer, marketer & distributor of Sucanon®, an oral Type-II Diabetes treatment, is pleased to introduce the two newest members of the Company's Board of...
Astellas Pharma US, Inc. ("Astellas"), a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the company has entered into a distribution agreement with Tecnofarma International Ltd. to...
Astellas Pharma US, Inc. ("Astellas"), a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the company has entered into a distribution agreement with Tecnofarma International Ltd. to...
Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, and collaborators Drs. Martin Kolb and Kjetil Ask at McMaster University announced today the measured advantages of inhaled GP-101 (aerosol...
Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, and collaborators Drs. Martin Kolb and Kjetil Ask at McMaster University announced today the measured advantages of inhaled GP-101 (aerosol...
Lipaglyn™ is the first Glitazar to be approved in the world and the first NCE discovered and developed indigenously by an Indian Pharma Company. The Zydus Group announced a breakthrough in its research efforts with...
Lipaglyn™ is the first Glitazar to be approved in the world and the first NCE discovered and developed indigenously by an Indian Pharma Company. The Zydus Group announced a breakthrough in its research efforts with...
DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced that its 1-for-12 reverse...
DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced that its 1-for-12 reverse...
LISLE, IL, June 4, 2013 /PRNewswire/ - Catamaran (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Tony Perkins, Investor Relations, will present at...
LISLE, IL, June 4, 2013 /PRNewswire/ - Catamaran (NASDAQ: CTRX) (TSX: CCT), a leading provider of technology and pharmacy benefit management (PBM) services, announces that Tony Perkins, Investor Relations, will present at...
Valeritas, makers of the V-Go® insulin delivery device, today announced that they have closed a structured debt financing with Capital Royalty L.P. which provides Valeritas with up to $100 million to further support the...
Valeritas, makers of the V-Go® insulin delivery device, today announced that they have closed a structured debt financing with Capital Royalty L.P. which provides Valeritas with up to $100 million to further support the...
MGT Capital Investments, Inc. (NYSE MKT: MGT) announced today that the Company has signed a definitive agreement with a major Asian conglomerate to sell its portfolio of medical imaging patents. The monetization of these...
MGT Capital Investments, Inc. (NYSE MKT: MGT) announced today that the Company has signed a definitive agreement with a major Asian conglomerate to sell its portfolio of medical imaging patents. The monetization of these...
An article published in Clinical Diabetes describes the clinical value of PreDx testing for more effective management of prediabetes patients in the primary care practice setting. The PreDx test is a predictive...
An article published in Clinical Diabetes describes the clinical value of PreDx testing for more effective management of prediabetes patients in the primary care practice setting. The PreDx test is a predictive...
Ambit Biosciences Corporation (Nasdaq: AMBI) announced today that multiple presentations from the Phase 2 ACE study of quizartinib (AC220), a FLT3 inhibitor, were presented at the Annual Meeting of the American Society of...
Ambit Biosciences Corporation (Nasdaq: AMBI) announced today that multiple presentations from the Phase 2 ACE study of quizartinib (AC220), a FLT3 inhibitor, were presented at the Annual Meeting of the American Society of...
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the availability of Accelrys Discoverant 4.3, the latest version of its industry-leading Process...
Accelrys, Inc. (NASDAQ: ACCL), a leading provider of scientific innovation lifecycle management software, has announced the availability of Accelrys Discoverant 4.3, the latest version of its industry-leading Process...
Phil Keoghan, host of "The Amazing Race" and founder of No Opportunity Wasted (NOW), joins Novartis Pharmaceuticals Corporation for the third year to raise awareness of multiple sclerosis (MS) through a unique campaign,...
Phil Keoghan, host of "The Amazing Race" and founder of No Opportunity Wasted (NOW), joins Novartis Pharmaceuticals Corporation for the third year to raise awareness of multiple sclerosis (MS) through a unique campaign,...
Alzheimer researchers in Spain have taken a step closer to finding a blood test to help in the diagnosis of Alzheimer's disease. With approximately 75% of the estimated 36 million Alzheimer's sufferers worldwide yet...
Alzheimer researchers in Spain have taken a step closer to finding a blood test to help in the diagnosis of Alzheimer's disease. With approximately 75% of the estimated 36 million Alzheimer's sufferers worldwide yet...
seca, the world's market leader in medical measuring and weighing, launches its medical Body Composition Analyzer, the seca mBCA 514. Equipped with an 8-point electrode Bioelectrical Impedance Analysis measurement...
seca, the world's market leader in medical measuring and weighing, launches its medical Body Composition Analyzer, the seca mBCA 514. Equipped with an 8-point electrode Bioelectrical Impedance Analysis measurement...
Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has acquired Tuttlingen, Germany-based NORMED Medizin-Technik GmbH, a provider of innovative technologies for the foot and ankle, hand and wrist...
Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH) announced today that it has acquired Tuttlingen, Germany-based NORMED Medizin-Technik GmbH, a provider of innovative technologies for the foot and ankle, hand and wrist...
